Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)
South Korea · Delayed Price · Currency is KRW 2,995.00
-140.00 (-4.47%)
At close: Apr 9, 2026
Vivozon Pharmaceutical Market Cap
Vivozon Pharmaceutical has a market cap or net worth of 148.4 billion as of April 10, 2026. Its market cap has decreased by -55.80% in one year.
Market Cap
148.40B
Enterprise Value
185.58B
Revenue
59.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,995.00
Market Cap Chart
Since November 18, 2005, Vivozon Pharmaceutical's market cap has increased from 72.45B to 148.40B, an increase of 104.83%. That is a compound annual growth rate of 3.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 180.19B | -10.21% |
| Dec 30, 2025 | 200.68B | -40.93% |
| Dec 30, 2024 | 339.73B | 134.89% |
| Dec 28, 2023 | 144.64B | -2.99% |
| Dec 29, 2022 | 149.09B | -19.87% |
| Dec 30, 2021 | 186.05B | -37.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| High Tech Pharm | 207.77B |
| OPTUS Pharmaceutical | 191.47B |
| Kyung Dong Pharmaceutical | 144.68B |
| Organoidsciences | 141.59B |
| DongKoo Bio & Pharma | 137.10B |
| PHARMARESEARCH BIO | 130.86B |
| HYUNDAI BIOLAND | 121.20B |
| KOREA PHARMA | 118.66B |